These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1071718)

  • 1. Renin inhibitory effect of synthetic phosphorylethanolamine (PE-104) in the rat.
    Miyazaki M; Yamamoto K; Hosoki K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():89s-91s. PubMed ID: 1071718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibitory effect of 2-[4-(4'-chlorophenoxy)phenoxyacetylamino]-ethylphosphorylethanolamine (PE-104) in vitro and in vivo.
    Hosoki K; Miyazaki M; Yamamoto K
    J Pharmacol Exp Ther; 1977 Nov; 203(2):485-92. PubMed ID: 909077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibition by synthetic phosphatidyl and phosphorylethanolamines.
    Miyazaki M; Hosoki K; Yamamoto K
    Jpn Circ J; 1976 Aug; 40(8):901-10. PubMed ID: 966372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic influence on the renin-angiotensin system. Evidence for a renin inhibitor in hypertension-prone rats.
    Iwai J; Knudsen KD; Dahl LK
    J Exp Med; 1970 Mar; 131(3):543-57. PubMed ID: 4312940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute hemodialysis-induced changes in sodium balance on the renin-angiotensin system in renovascular and spontaneously hypertensive rats.
    Röckel A; Brand A; Bechinger W; Heidland A
    Res Exp Med (Berl); 1979 Oct; 176(1):7-14. PubMed ID: 523796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of renin suppression by angiotensin II in hypertension.
    Williams GH; Hollenberg NK; Moore TJ; Dluhy RG; Bavli SZ; Solomon HS; Mersey JH
    Circ Res; 1978 Jan; 42(1):46-52. PubMed ID: 618602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of dog renin activity by pepstatin A.
    Miyazaki M; Komori T; Okunishi H; Toda N
    Jpn Circ J; 1979 Sep; 43(9):818-23. PubMed ID: 501901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of renin-angiotensin system in chronic renal hypertensive rats.
    Sen S; Smeby RR; Bumpus FM; Turcotte JG
    Hypertension; 1979; 1(4):427-34. PubMed ID: 232087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of blood pressure to infusion of angiotensin II: relation to plasma concentrations of renin and angiotensin II.
    Chinn RH; Düsterdieck G
    Clin Sci; 1972 Apr; 42(4):489-504. PubMed ID: 4336431
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the renin-angiotensin system in normotensive and hypertensive rats with varying renin status.
    Atkinson J; Boillat N; Essadki A; Lüthi P; Maranda B; Sonnay M
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):301-15. PubMed ID: 3555376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma renin activity in hypertensive rats after treatment with renin preinhibitor.
    Sen S; Smeby RR; Bumpus FM
    Am J Physiol; 1969 Mar; 216(3):499-503. PubMed ID: 4303901
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure and plasma angiotensin II concentration after renal artery constriction and angiotensin infusion in the dog. (5-Isoleucine)angiotensin II and its breakdown fragments in dog blood.
    Caravaggi AM; Bianchi G; Brown JJ; Lever AF; Morton JJ; Powell-Jackson JD; Robertson JI; Semple PF
    Circ Res; 1976 Apr; 38(4):315-21. PubMed ID: 1260974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin--angiotensin antagonists and the regulation of blood pressure.
    Samuels AI; Miller ED; Fray JC; Haber E; Barger AC
    Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an angiotensin II antagonist; [sarcosine 1, isoleucine 8] angiotensin II, on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive and normotensive subjects taking oral contraceptives.
    Ogihara T; Hata T; Maruyama A; Nakamaru M; Mikami H; Kumahara Y
    Endocrinol Jpn; 1979 Oct; 26(5):591-7. PubMed ID: 393505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.